- Homologous Recombination Deficiencies and Hereditary Tumors.
- Yamamoto H, Hirasawa A.
- Int J Mol Sci. 2021 Dec 29;23(1):348. doi: 10.3390/ijms23010348.
- Review
- Free Full Text
- BRCA1 and BRCA2 pathogenic variants and prostate cancer risk: systematic review and meta-analysis.
- Nyberg T, Tischkowitz M, Antoniou AC.
- Br J Cancer. 2021 Dec 28. doi: 10.1038/s41416-021-01675-5. Epub ahead of print.
- PMID: 34963702
- PubMed abstract
- Meta-Analysis. Review.
- Free Full Text
- A dangerous breast cancer gene mutation changed my life. As a health reporter, I want you to know about it. The PALB2 mutation is lesser-known than BRCA. It’s time to change that.
- Berger S.
- The Lily. (Washington Post). 2021 Dec 27.
- Press
- Free Full Text